Biotechnology Spinal Delivery Of Taysha’s Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease – Taysha Gene Therapies (NASDAQ:TSHA) Read more
Biotechnology Taysha Gene Therapies Stock Soars On FY23 Results: Here’s Why – Taysha Gene Therapies (NASDAQ:TSHA) Read more
Biotechnology Taysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental Disorder – Taysha Gene Therapies (NASDAQ:TSHA) Read more
Biotechnology Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform – Voyager Therapeutics (NASDAQ:VYGR) Read more
Biotechnology This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology Novartis Reveals Promising Gene Therapy Data for Treating Spinal Muscular Atrophy in Older Children – Novartis (NYSE:NVS) Read more
Opinion Thinking about buying stock in BioNexus Gene Lab, Gladstone Investment Corp, Canopy Growth Corp, Recursion Pharmaceuticals, or Monolithic Power Systems? – BioNexus Gene Lab (NASDAQ:BGLC), Canopy Gwth (NASDAQ:CGC) Read more
Eurozone Dow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In January – BioNexus Gene Lab (NASDAQ:BGLC), Biolase (NASDAQ:BIOL) Read more
Biotechnology Gene Therapy Player REGENXBIO’s RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst – Regenxbio (NASDAQ:RGNX) Read more